PROCTER & GAMBLE HEALTH
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Procter & Gamble Health along with daily highs, lows, percentage changes and volume trends, and, all financial information.
0.35₹ 21.7
As on Oct 31, 2025, 4:01 PM IST
Procter & Gamble Health Price Performance
Today's LowToday's High
₹6,105.55₹6,206.05
₹6,203.00
52 Weeks' Low52 Weeks' High
₹4,916.00₹6,700.00
₹6,203.00
Open Price
₹6,134.00
Prev. Close
₹6,181.30
Volume
418
Over the last 5 years, the share price of Procter & Gamble Health has gained 3.50% CAGR. Over the past year, the corresponding return has been 18.51%.
Procter & Gamble Health’s current P/E of 34.25x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Highest YOY Quarterly profit growth Screener.
Procter & Gamble Health Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Procter & Gamble Health | 1.71 | -1.40 | 5.14 | 22.47 | 18.51 | 15.38 | 3.50 |
| Sun Pharmaceutical Industries | -0.57 | 3.28 | -0.92 | -7.60 | -8.61 | 18.48 | 29.21 |
| Divi's Laboratories | 2.65 | 18.41 | 2.45 | 10.85 | 14.73 | 23.31 | 17.28 |
| Cipla | -5.18 | -0.81 | -3.38 | -1.58 | -3.32 | 8.79 | 14.87 |
| Torrent Pharmaceuticals | -0.80 | -0.38 | -5.14 | 9.01 | 10.85 | 29.10 | 22.78 |
| Dr. Reddy's Laboratories | -6.61 | -3.78 | -5.65 | 1.37 | -5.90 | 10.60 | 4.30 |
| Mankind Pharma | -2.15 | -2.43 | -7.34 | -0.11 | -10.77 | 18.66 | 10.81 |
| Zydus Lifesciences | -3.15 | -1.79 | 0.41 | 10.00 | -2.78 | 30.95 | 18.88 |
| Lupin | 1.95 | -0.64 | 2.09 | -4.31 | -9.93 | 41.27 | 16.64 |
| Aurobindo Pharma | 4.93 | 4.74 | -0.20 | -6.06 | -18.43 | 28.36 | 8.42 |
| Alkem Laboratories | -0.73 | 0.83 | 9.42 | 8.53 | -4.81 | 20.39 | 15.68 |
| Abbott India | -3.15 | -2.92 | -15.75 | -5.70 | 0.08 | 14.62 | 13.33 |
| Glenmark Pharmaceuticals | 3.96 | -3.48 | -11.38 | 37.43 | 11.65 | 67.21 | 31.92 |
| Laurus Labs | 2.79 | 9.06 | 8.79 | 53.32 | 93.35 | 27.90 | 25.89 |
| Biocon | 3.58 | 7.36 | -4.88 | 16.74 | 17.67 | 11.37 | -1.64 |
| GlaxoSmithKline Pharmaceuticals | -4.63 | -2.66 | -16.95 | -8.04 | -3.56 | 23.95 | 13.23 |
| Anthem Biosciences | -1.31 | -7.94 | -6.37 | -2.73 | -2.73 | -0.92 | -0.55 |
| Ipca Laboratories | 0.17 | -4.35 | -13.80 | -7.87 | -20.02 | 11.98 | 2.00 |
| Gland Pharma | -0.60 | -2.66 | -6.66 | 37.25 | 16.79 | 2.61 | 1.15 |
| Ajanta Pharma | 2.22 | 2.85 | -10.32 | -4.54 | -19.69 | 23.86 | 18.63 |
Over the last one year, Procter & Gamble Health has gained 18.51% compared to peers like Sun Pharmaceutical Industries (-8.61%), Divi's Laboratories (14.73%), Cipla (-3.32%). From a 5 year perspective, Procter & Gamble Health has underperformed peers relative to Sun Pharmaceutical Industries (29.21%) and Divi's Laboratories (17.28%).
Procter & Gamble Health Financials
Procter & Gamble Health Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 6,144.02 | 6,169.9 |
| 10 | 6,166.72 | 6,169.98 |
| 20 | 6,193.65 | 6,190.11 |
| 50 | 6,282.45 | 6,193.18 |
| 100 | 6,097.35 | 6,063.13 |
| 200 | 5,689.25 | 5,822.79 |
Procter & Gamble Health Share Holding Pattern
In the latest quarter, Procter & Gamble Health saw a rise in promoter holding to 103.64%, while DII stake decreased to 13.90%, FII holding rose to 7.24%, and public shareholding moved up to 27.05% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Procter & Gamble Health Stock Mutual Fund Holdings
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 6,92,659 | 0.66 | 436.89 | |
| 3,56,022 | 2.66 | 224.56 | |
| 2,40,895 | 5.31 | 151.94 | |
| 75,751 | 0.77 | 47.78 | |
| 69,716 | 1.19 | 43.97 | |
| 69,320 | 3.99 | 43.72 | |
| 12,000 | 0.45 | 7.57 | |
| 3,653 | 3.09 | 2.3 | |
| 1,831 | 3.2 | 1.15 | |
| 1,748 | 3.29 | 1.1 |
* Excluding Index & Arbitrage Funds
Procter & Gamble Health Corporate Actions
Date Time | Announcement |
|---|---|
| Oct 20, 2025, 11:15 PM IST | P&G Health - Revision of Board Meeting |
| Oct 20, 2025, 10:49 PM IST | P&G Health - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Oct 02, 2025, 2:42 AM IST | P&G Health - Allotment Of DIN To Mr. Shashank Srowthy, Executive Director |
| Sep 29, 2025, 11:43 PM IST | P&G Health - Board Meeting Intimation for Intimation Of Board Meeting Scheduled To Be Held On November 5, 2025 |
| Sep 16, 2025, 11:52 PM IST | P&G Health - Announcement under Regulation 30 (LODR)-Change in Management |
About Procter & Gamble Health
Procter & Gamble Health Ltd. is a Public Limited Listed company incorporated on 26/04/1967 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L99999MH1967PLC013726 and registration number is 013726. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company's Total Operating Revenue is Rs. 934.17 Cr. and Equity Capital is Rs. 16.60 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressP&G Plaza, Cardinal Gracias Road, Mumbai Maharashtra 400009
- Contact
Management
- Mr. S MadhavanChairman & Ind.Director
- Mr. Milind ThatteManaging Director
- Mr. Lokesh ChandakExecutive Director & CFO
- Ms. Seema SambasivanNon Executive Director
- Mr. Aalok AgrawalNon Executive Director
- Ms. Krishna SarmaIndependent Director
- Mr. Sharad TyagiIndependent Director
FAQs on Procter & Gamble Health Share Price
What is the share price of Procter & Gamble Health?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Procter & Gamble Health is ₹6,203.00 as on Oct 31, 2025.
What kind of stock is Procter & Gamble Health?
The Procter & Gamble Health is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Procter & Gamble Health?
The market cap of Procter & Gamble Health is ₹10,296.60 Cr as on Oct 31, 2025.
What are today's High and Low prices of Procter & Gamble Health?
Today’s highest and lowest price of Procter & Gamble Health are ₹6,206.05 and ₹6,105.55.
What are the 52 Week High and 52 Week Low of Procter & Gamble Health?
The 52-week high/low is the highest and lowest price at which Procter & Gamble Health stock has traded in the past 52-week or nearly a year. The 52-week high of Procter & Gamble Health is ₹6,700.00 and 52-week low of Procter & Gamble Health is ₹4,916.00 as on Oct 31, 2025.
How has the Procter & Gamble Health performed historically in terms of returns?
The Procter & Gamble Health has shown returns of 0.35% over the past day, -1.4% for the past month, 5.14% over 3 months, 18.51% over 1 year, 15.38% across 3 years, and 3.5% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Procter & Gamble Health?
P/E ratio of and PB ratio of Procter & Gamble Health are 34.25 and 16.59 on Oct 31, 2025. While the company gives a dividend yield of 2.02 per annum.
✕
Market Pulse